Maged Costantine
Ohio State University · UTexasGalveston; Ohio State
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Maged Costantine as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:38 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06468202 · Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIALOhio State University · recruiting · Hypertensive Disorders of Pregnancy, Preeclampsia, Gestational Hypertension · principal investigator
- N/ANCT06249178 · EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)Ohio State University · recruiting · Preeclampsia · principal investigator
- N/ANCT04474704 · Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe PreeclampsiaOhio State University · completed · Preeclampsia With Severe Features · principal investigator
- Ph3NCT03944512 · Pravastatin to Prevent PreeclampsiaThe George Washington University Biostatistics Center · terminated · Preeclampsia, Obstetric Labor Complications, Hypertension in Pregnancy · principal investigator
- Ph1NCT01717586 · Pravastatin for Prevention of PreeclampsiaThe University of Texas Medical Branch, Galveston · completed · Preeclampsia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During PregnancyR24HD113024 · NICHD · OHIO STATE UNIVERSITY · fiscal years 2023 to 2026 · $991,796 awarded in 2026Grant number is on one of their registry trials
- NICHD maternal fetal medicine units networkUG1HD027915 · NICHD · OHIO STATE UNIVERSITY · fiscal years 2019 to 2026 · $330,399 awarded in 2026Same name and institution; not confirmed by an ID
- 1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk womenUH3HL140131 · NHLBI · OHIO STATE UNIVERSITY · fiscal years 2019 to 2023 · $1 awarded in 2023Same name and institution; not confirmed by an ID
- Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant womenU54HD047891 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2015 to 2019 · $278,588 awarded in 2019Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Data Coord Ctr-NICHD Cooperative Multicenter Maternal Medicine Units Research NetU10HD036801 · NICHD · GEORGE WASHINGTON UNIVERSITY · PI Rebecca Gersnoviez Clifton · fiscal years 2009 to 2021Named on NCT03944512
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:38 UTC. The ranking covers the 200 most relevant of 40 PubMed records, and a shared surname and initials can bring in a namesake. All 40 on PubMed
- Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial.Am J Obstet Gynecol · 2016214 citationsRCR 9.4
- 110 citationsRCR 8.1
- A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia.Am J Obstet Gynecol · 202178 citationsRCR 5.6
- Racial and Ethnic Inequities in Cesarean Birth and Maternal Morbidity in a Low-Risk, Nulliparous Cohort.Obstet Gynecol · 202248 citationsRCR 5.9
- Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes.J Matern Fetal Neonatal Med · 201922 citationsRCR 1.3
- Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.Obstet Gynecol · 202022 citationsRCR 1.7
- Effect of Thyroxine Therapy on Depressive Symptoms Among Women With Subclinical Hypothyroidism.Obstet Gynecol · 202018 citationsRCR 1.4
- Population versus customized fetal growth norms and adverse outcomes in an intrapartum cohort.Am J Perinatol · 201315 citationsRCR 0.7
- Customized versus population approach for evaluation of fetal overgrowth.Am J Perinatol · 201315 citationsRCR 0.7
- Association between Hypertensive Disorders of Pregnancy and Long-Term Neurodevelopmental Outcomes in the Offspring.Am J Perinatol · 202214 citationsRCR 1.7